Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,873 | 26,412 | 7,818 | -5,885 | -4,315 |
| Depreciation Amortization | 2,033 | 1,537 | 1,026 | 512 | 2,137 |
| Income taxes - deferred | 10,543 | 8,040 | 6,562 | 4,885 | 3,795 |
| Accounts receivable | -31,563 | -20,207 | -12,415 | -7,223 | -9,905 |
| Other Working Capital | -27,922 | -25,192 | -10,968 | -7,109 | -15,166 |
| Other Operating Activity | 25,785 | 24,011 | 27,857 | 29,596 | 30,910 |
| Operating Cash Flow | $23,748 | $14,602 | $19,880 | $14,776 | $7,456 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -926 | -528 | -322 | -218 | -1,500 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -900 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -900 |
| Investing Cash Flow | $-926 | $-528 | $-322 | $-218 | $-2,400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,380 | -4,283 | -4,257 | -4,092 | -336 |
| Common Stock Issued | 319 | 240 | 150 | N/A | 19 |
| Other Financing Activity | -261 | -238 | -140 | -39 | -509 |
| Financing Cash Flow | $-4,322 | $-4,281 | $-4,247 | $-4,131 | $-826 |
| Beginning Cash Position | 11,769 | 11,769 | 11,769 | 11,769 | 7,539 |
| End Cash Position | 30,269 | 21,563 | 27,081 | 22,196 | 11,769 |
| Net Cash Flow | $18,500 | $9,793 | $15,311 | $10,427 | $4,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,748 | 14,602 | 19,880 | 14,776 | 7,456 |
| Capital Expenditure | -926 | -528 | -322 | -218 | -1,625 |
| Free Cash Flow | 22,823 | 14,074 | 19,559 | 14,558 | 5,831 |